Disruption of the gut microbiome as a risk factor for microbial infections

Current Opinion in Microbiology

Volumn 16, Issue 2, 2013, Pages 221-227

  Khosravi, Arya ^a   Mazmanian, Sarkis K ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL INFECTION; COMMENSALISM; DISEASE PREDISPOSITION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; INTESTINE FLORA; LIFESTYLE; MEDICAL PRACTICE; NONHUMAN; REVIEW; RISK ASSESSMENT; SYMBIOSIS; VALIDATION PROCESS;

BIOTA; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; METAGENOME; MODELS, BIOLOGICAL; RISK FACTORS; SYMBIOSIS;

BACTERIA (MICROORGANISMS);

EID: 84877026861     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.03.009     Document Type: Review

References (38)

1. Alanis A.J. Resistance to antibiotics: are we in the post-antibiotic era?. Arch Med Res 2005, 36:697-705.
2. Kahrstrom C.T. Entering a post-antibiotic era?. Nat Rev Microbiol 2013, 11:146.
3. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346:334-339.
4. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449.
5. Brandt L.J., Aroniadis O.C., Mellow M., Kanatzar A., Kelly C., et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012, 107:1079-1087.
6. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
7. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
8. Rhee S.H., Pothoulakis C., Mayer E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009, 6:306-314.
9. Reid G., Howard J., Gan B.S. Can bacterial interference prevent infection?. Trends Microbiol 2001, 9:424-428.
10. Kamada N., Kim Y.G., Sham H.P., Vallance B.A., Puente J.L., et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012, 336:1325-1329.
11. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., et al. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007, 5:e244.
12. Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae. Cell Host Microbe 2007, 2:119-129.
13. Sekirov I., Tam N.M., Jogova M., Robertson M.L., Li Y., et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008, 76:4726-4736.
14. Petersson J., Schreiber O., Hansson G.C., Gendler S.J., Velcich A., et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011, 300:G327-G333.
15. Moreau M.C., Ducluzeau R., Guy-Grand D., Muller M.C. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect Immun 1978, 21:532-539.
16. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010, 10:159-169.
17. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
18. Vaishnava S., Yamamoto M., Severson K.M., Ruhn K.A., Yu X., et al. The antibacterial lectin RegIIIγ promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
19. Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
20. Rathinam V.A.K., Vanaja S.K., Fitzgerald K.A. Regulation of inflammasome signaling. Nat Immunol 2012, 13:332-342.
21. Franchi L., Kamada N., Nakamura Y., Burberry A., Kuffa P., et al. NLRC4-driven production of IL-1beta discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat Immunol 2012, 13:449-456.
22. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
23. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
24. Naik S., Bouladoux N., Wilhelm C., Molloy M.J., Salcedo R., et al. Compartmentalized control of skin immunity by resident commensals. Science 2012, 337:1115-1119.
25. Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 2011, 108:5354-5359.
26. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
27. Abt Michael C., Osborne Lisa C., Monticelli Laurel A., Doering Travis A., Alenghat T., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
28. Ganal Stephanie C., Sanos Stephanie L., Kallfass C., Oberle K., Johner C., et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012, 37:171-186.
29. Clarke T.B., Davis K.M., Lysenko E.S., Zhou A.Y., Yu Y., et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010, 16:228-231.
30. Bäckhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007, 104:979-984.
31. Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4554-4561.
32. Ubeda C., Taur Y., Jenq R.R., Equinda M.J., Son T., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010, 120:4332-4341.
33. Jakobsson H.E., Jernberg C., Andersson A.F., Sjolund-Karlsson M., Jansson J.K., et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 2010, 5:e9836.
34. Maeda S., Hsu L.-C., Liu H., Bankston L.A., Iimura M., et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1ß processing. Science 2005, 307:734-738.
35. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
36. Eaves-Pyles T., Allen C.A., Taormina J., Swidsinski A., Tutt C.B., et al. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol 2008, 298:397-409.
37. Willing B.P., Vacharaksa A., Croxen M., Thanachayanont T., Finlay B.B. Altering host resistance to infections through microbial transplantation. PLoS ONE 2011, 6:e26988.
38. Blaser M.J., Falkow S. What are the consequences of the disappearing human microbiota?. Nat Rev Microbiol 2009, 7:887-894.